Home ETF List About

Portfolio Holdings Detail for ISIN IE00BMWPV470
Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /var/www/liquidata/show_ticker_holding_ETFs.php on line 77
Stock Name / FundiShares MSCI USA SRI UCITS ETF GBP Hedged (Dist)
IssuerBlackrock
ETF TickerSUAP(GBP) LSE
ETF TickerSUAP.LS(GBP) CXE
ETF TickerSUAP.L(GBP) LSE

Holdings detail for RPRX

Stock NameRoyalty Pharma Plc
TickerRPRX(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINGB00BMVP7Y09
LEI549300FGFN7VOK8BZR03

Show aggregate RPRX holdings

News associated with RPRX

Allianz Asset Management GmbH Has $6.03 Million Stock Holdings in Royalty Pharma PLC (NASDAQ:RPRX)
Allianz Asset Management GmbH reduced its holdings in shares of Royalty Pharma PLC (NASDAQ:RPRX – Free Report) by 64.8% during the 1st quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 193,591 shares of the biopharmaceutical company’s stock after selling 356,968 shares during the period. Allianz […] - 2025-07-28 10:00:47
Edgestream Partners L.P. Invests $659,000 in Royalty Pharma PLC (NASDAQ:RPRX)
Edgestream Partners L.P. acquired a new position in shares of Royalty Pharma PLC (NASDAQ:RPRX – Free Report) in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm acquired 21,158 shares of the biopharmaceutical company’s stock, valued at approximately $659,000. Other hedge funds and other institutional investors also […] - 2025-07-20 08:24:59
Cerity Partners LLC Boosts Stake in Royalty Pharma PLC (NASDAQ:RPRX)
Cerity Partners LLC raised its stake in shares of Royalty Pharma PLC (NASDAQ:RPRX – Free Report) by 786.3% during the 1st quarter, Holdings Channel reports. The fund owned 153,846 shares of the biopharmaceutical company’s stock after purchasing an additional 136,487 shares during the period. Cerity Partners LLC’s holdings in Royalty Pharma were worth $4,789,000 as […] - 2025-07-17 08:00:57
Xponance Inc. Acquires 1,437 Shares of Royalty Pharma PLC (NASDAQ:RPRX)
Xponance Inc. raised its holdings in shares of Royalty Pharma PLC (NASDAQ:RPRX – Free Report) by 3.7% in the first quarter, HoldingsChannel.com reports. The firm owned 40,133 shares of the biopharmaceutical company’s stock after buying an additional 1,437 shares during the period. Xponance Inc.’s holdings in Royalty Pharma were worth $1,249,000 as of its most […] - 2025-07-16 08:48:56
M&T Bank Corp Buys 5,500 Shares of Royalty Pharma PLC (NASDAQ:RPRX)
M&T Bank Corp raised its stake in shares of Royalty Pharma PLC (NASDAQ:RPRX – Free Report) by 23.4% in the 1st quarter, Holdings Channel reports. The firm owned 28,967 shares of the biopharmaceutical company’s stock after acquiring an additional 5,500 shares during the period. M&T Bank Corp’s holdings in Royalty Pharma were worth $902,000 at […] - 2025-07-15 09:23:30
Teacher Retirement System of Texas Cuts Stock Position in Royalty Pharma PLC (NASDAQ:RPRX)
Teacher Retirement System of Texas cut its holdings in shares of Royalty Pharma PLC (NASDAQ:RPRX – Free Report) by 10.4% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 103,364 shares of the biopharmaceutical company’s stock after selling 12,028 shares during the […] - 2025-07-09 08:33:01
Allspring Global Investments Holdings LLC Boosts Stake in Royalty Pharma PLC (NASDAQ:RPRX)
Allspring Global Investments Holdings LLC boosted its position in shares of Royalty Pharma PLC (NASDAQ:RPRX – Free Report) by 4.0% in the first quarter, Holdings Channel.com reports. The institutional investor owned 561,724 shares of the biopharmaceutical company’s stock after acquiring an additional 21,729 shares during the period. Allspring Global Investments Holdings LLC’s holdings in Royalty […] - 2025-07-03 09:09:03
11,210 Shares in Royalty Pharma PLC (NASDAQ:RPRX) Acquired by Kentucky Retirement Systems Insurance Trust Fund
Kentucky Retirement Systems Insurance Trust Fund acquired a new stake in shares of Royalty Pharma PLC (NASDAQ:RPRX – Free Report) in the first quarter, HoldingsChannel reports. The firm acquired 11,210 shares of the biopharmaceutical company’s stock, valued at approximately $349,000. Other hedge funds also recently bought and sold shares of the company. Louisbourg Investments Inc. […] - 2025-06-26 08:42:57
After Hours Most Active for Jun 24, 2025 : SNAP, NVDA, CMCSA, PLTR, INTC, SPR, AUR, RPRX, KVUE, MPW, GM, WMT
The NASDAQ 100 After Hours Indicator is down -.81 to 22,189.71. The total After hours volume is currently 173,627,396 shares traded.The following are the most active stocks for the after hours session: Snap Inc. (SNAP) is unchanged at $8.32, with 14,501,942 shares traded. SNAP's - 2025-06-24 20:24:56
Manning & Napier Advisors LLC Sells 44,505 Shares of Royalty Pharma PLC (NASDAQ:RPRX)
Manning & Napier Advisors LLC lessened its holdings in shares of Royalty Pharma PLC (NASDAQ:RPRX – Free Report) by 54.9% during the first quarter, HoldingsChannel.com reports. The firm owned 36,549 shares of the biopharmaceutical company’s stock after selling 44,505 shares during the quarter. Manning & Napier Advisors LLC’s holdings in Royalty Pharma were worth $1,138,000 […] - 2025-06-24 08:20:57
After Hours Most Active for Jun 11, 2025 : PLTR, NVDA, AMZN, AAPL, RPRX, MCHPP
The NASDAQ 100 After Hours Indicator is up 14.32 to 21,875.12. The total After hours volume is currently 131,070,110 shares traded.The following are the most active stocks for the after hours session: Palantir Technologies Inc. (PLTR) is +0.25 at $136.64, with 5,538,416 shares t - 2025-06-11 20:24:56
Rhumbline Advisers Has $14.01 Million Position in Royalty Pharma plc (NASDAQ:RPRX)
Rhumbline Advisers lowered its holdings in shares of Royalty Pharma plc (NASDAQ:RPRX – Free Report) by 0.9% during the first quarter, HoldingsChannel reports. The firm owned 449,964 shares of the biopharmaceutical company’s stock after selling 4,184 shares during the quarter. Rhumbline Advisers’ holdings in Royalty Pharma were worth $14,007,000 as of its most recent SEC […] - 2025-06-09 08:24:51
Lazard Asset Management LLC Reduces Holdings in Royalty Pharma plc (NASDAQ:RPRX)
Lazard Asset Management LLC lowered its stake in shares of Royalty Pharma plc (NASDAQ:RPRX – Free Report) by 4.6% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 23,457 shares of the biopharmaceutical company’s stock after selling 1,130 shares during the quarter. Lazard Asset […] - 2025-05-22 08:46:49
Royalty Pharma plc (NASDAQ:RPRX) Receives Average Rating of “Buy” from Brokerages
Royalty Pharma plc (NASDAQ:RPRX – Get Free Report) has received a consensus recommendation of “Buy” from the five research firms that are covering the stock, Marketbeat Ratings reports. One analyst has rated the stock with a hold rating, three have given a buy rating and one has given a strong buy rating to the company. […] - 2025-05-22 07:50:51
Captrust Financial Advisors Sells 14,499 Shares of Royalty Pharma plc (NASDAQ:RPRX)
Captrust Financial Advisors reduced its position in shares of Royalty Pharma plc (NASDAQ:RPRX – Free Report) by 49.4% in the 4th quarter, Holdings Channel.com reports. The institutional investor owned 14,829 shares of the biopharmaceutical company’s stock after selling 14,499 shares during the quarter. Captrust Financial Advisors’ holdings in Royalty Pharma were worth $378,000 as of […] - 2025-05-20 07:52:44
Analysts Predict 10% Gains Ahead For The Holdings of EUSA
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-05-19 10:59:43
Royalty Pharma (NASDAQ:RPRX) Raised to “Buy” at StockNews.com
Royalty Pharma (NASDAQ:RPRX – Get Free Report) was upgraded by stock analysts at StockNews.com from a “hold” rating to a “buy” rating in a note issued to investors on Monday. Separately, Citigroup reiterated a “buy” rating on shares of Royalty Pharma in a research report on Friday, March 28th. One equities research analyst has rated […] - 2025-05-14 05:14:45
Stifel Financial Corp Lowers Stake in Royalty Pharma plc (NASDAQ:RPRX)
Stifel Financial Corp reduced its stake in shares of Royalty Pharma plc (NASDAQ:RPRX – Free Report) by 11.4% in the fourth quarter, Holdings Channel reports. The firm owned 17,152 shares of the biopharmaceutical company’s stock after selling 2,200 shares during the period. Stifel Financial Corp’s holdings in Royalty Pharma were worth $438,000 at the end […] - 2025-05-13 07:50:58
Prudential Financial Inc. Has $488,000 Stake in Royalty Pharma plc (NASDAQ:RPRX)
Prudential Financial Inc. lowered its holdings in Royalty Pharma plc (NASDAQ:RPRX – Free Report) by 4.9% during the fourth quarter, Holdings Channel.com reports. The firm owned 18,360 shares of the biopharmaceutical company’s stock after selling 955 shares during the period. Prudential Financial Inc.’s holdings in Royalty Pharma were worth $488,000 at the end of the […] - 2025-04-10 08:01:02
American Century Companies Inc. Boosts Holdings in Royalty Pharma plc (NASDAQ:RPRX)
American Century Companies Inc. grew its holdings in shares of Royalty Pharma plc (NASDAQ:RPRX – Free Report) by 5.8% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 67,160 shares of the biopharmaceutical company’s stock after buying an additional 3,671 shares […] - 2025-04-10 07:26:56
Royalty Pharma plc (NASDAQ:RPRX) Shares Purchased by JPMorgan Chase & Co.
JPMorgan Chase & Co. lifted its stake in Royalty Pharma plc (NASDAQ:RPRX – Free Report) by 8.2% in the 4th quarter, Holdings Channel reports. The firm owned 1,395,242 shares of the biopharmaceutical company’s stock after purchasing an additional 105,824 shares during the quarter. JPMorgan Chase & Co.’s holdings in Royalty Pharma were worth $35,593,000 at […] - 2025-04-08 07:44:55
Schroder Investment Management Group Sells 354,483 Shares of Royalty Pharma plc (NASDAQ:RPRX)
Schroder Investment Management Group lowered its stake in shares of Royalty Pharma plc (NASDAQ:RPRX – Free Report) by 64.4% during the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 196,359 shares of the biopharmaceutical company’s stock after selling 354,483 shares during the quarter. Schroder Investment Management […] - 2025-04-06 08:29:08
Analysts Set Royalty Pharma plc (NASDAQ:RPRX) PT at $41.60
Shares of Royalty Pharma plc (NASDAQ:RPRX – Get Free Report) have earned a consensus rating of “Buy” from the six research firms that are presently covering the firm, Marketbeat reports. One research analyst has rated the stock with a hold rating, four have given a buy rating and one has issued a strong buy rating […] - 2025-03-31 05:14:52
Stock Traders Buy High Volume of Royalty Pharma Put Options (NASDAQ:RPRX)
Royalty Pharma plc (NASDAQ:RPRX – Get Free Report) saw some unusual options trading on Thursday. Stock traders purchased 4,237 put options on the stock. This is an increase of 344% compared to the typical volume of 954 put options. Institutional Trading of Royalty Pharma Institutional investors and hedge funds have recently modified their holdings of […] - 2025-03-28 07:07:01
Royalty Pharma plc (NASDAQ:RPRX) Shares Acquired by Corient Private Wealth LLC
Corient Private Wealth LLC lifted its position in Royalty Pharma plc (NASDAQ:RPRX – Free Report) by 86.0% during the fourth quarter, HoldingsChannel.com reports. The fund owned 46,249 shares of the biopharmaceutical company’s stock after acquiring an additional 21,383 shares during the period. Corient Private Wealth LLC’s holdings in Royalty Pharma were worth $1,180,000 at the […] - 2025-03-27 08:10:50
Royalty Pharma plc (NASDAQ:RPRX) Stake Lowered by HighTower Advisors LLC
HighTower Advisors LLC decreased its stake in Royalty Pharma plc (NASDAQ:RPRX – Free Report) by 5.0% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 173,411 shares of the biopharmaceutical company’s stock after selling 9,177 shares during the period. HighTower Advisors […] - 2025-03-20 07:45:04
Royalty Pharma plc (NASDAQ:RPRX) Shares Purchased by M&T Bank Corp
M&T Bank Corp boosted its stake in Royalty Pharma plc (NASDAQ:RPRX – Free Report) by 25.2% during the 4th quarter, HoldingsChannel reports. The fund owned 23,467 shares of the biopharmaceutical company’s stock after buying an additional 4,718 shares during the period. M&T Bank Corp’s holdings in Royalty Pharma were worth $599,000 as of its most […] - 2025-03-13 07:47:00
Royalty Pharma plc (NASDAQ:RPRX) Shares Acquired by Victory Capital Management Inc.
Victory Capital Management Inc. raised its holdings in shares of Royalty Pharma plc (NASDAQ:RPRX – Free Report) by 15.2% in the 4th quarter, HoldingsChannel.com reports. The fund owned 978,211 shares of the biopharmaceutical company’s stock after buying an additional 129,176 shares during the quarter. Victory Capital Management Inc.’s holdings in Royalty Pharma were worth $24,954,000 […] - 2025-03-11 08:58:55
State of Michigan Retirement System Buys 2,700 Shares of Royalty Pharma plc (NASDAQ:RPRX)
State of Michigan Retirement System boosted its stake in shares of Royalty Pharma plc (NASDAQ:RPRX – Free Report) by 16.2% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 19,400 shares of the biopharmaceutical company’s stock after purchasing an additional […] - 2025-03-10 08:44:52
Allworth Financial LP Raises Position in Royalty Pharma plc (NASDAQ:RPRX)
Allworth Financial LP lifted its stake in Royalty Pharma plc (NASDAQ:RPRX – Free Report) by 417.6% in the 4th quarter, Holdings Channel.com reports. The institutional investor owned 1,087 shares of the biopharmaceutical company’s stock after acquiring an additional 877 shares during the quarter. Allworth Financial LP’s holdings in Royalty Pharma were worth $28,000 as of […] - 2025-02-27 08:28:51

iShares MSCI USA SRI UCITS ETF GBP Hedged (Dist) RPRX holdings

DateNumber of RPRX Shares HeldBase Market Value of RPRX SharesLocal Market Value of RPRX SharesChange in RPRX Shares HeldChange in RPRX Base ValueCurrent Price per RPRX Share HeldPrevious Price per RPRX Share Held
2025-07-28 (Monday)114,558USD 4,245,519USD 4,245,519
2025-07-25 (Friday)115,269USD 4,226,914USD 4,226,914
2025-07-24 (Thursday)115,269USD 4,217,693USD 4,217,693
2025-07-23 (Wednesday)115,349USD 4,153,717USD 4,153,717
2025-07-22 (Tuesday)116,534USD 4,206,877USD 4,206,877
2025-07-21 (Monday)116,613USD 4,157,253USD 4,157,253
2025-07-18 (Friday)116,613USD 4,150,257USD 4,150,257
2025-07-17 (Thursday)116,533USD 4,133,426USD 4,133,426
2025-07-16 (Wednesday)116,454USD 4,145,762USD 4,145,762
2025-07-15 (Tuesday)117,086USD 4,274,810USD 4,274,810
2025-07-14 (Monday)117,560USD 4,260,374USD 4,260,374
2025-07-11 (Friday)117,560USD 4,213,350USD 4,213,350
2025-07-10 (Thursday)117,244RPRX holding increased by 474USD 4,234,853RPRX holding increased by 46313USD 4,234,853474USD 46,313 USD 36.12 USD 35.87
2025-07-09 (Wednesday)116,770RPRX holding decreased by -395USD 4,188,540RPRX holding increased by 28011USD 4,188,540-395USD 28,011 USD 35.87 USD 35.51
2025-07-08 (Tuesday)117,165RPRX holding decreased by -2172USD 4,160,529RPRX holding decreased by -86675USD 4,160,529-2,172USD -86,675 USD 35.51 USD 35.59
2025-07-07 (Monday)119,337USD 4,247,204RPRX holding decreased by -93083USD 4,247,2040USD -93,083 USD 35.59 USD 36.37
2025-07-04 (Friday)119,337USD 4,340,287USD 4,340,2870USD 0 USD 36.37 USD 36.37
2025-07-03 (Thursday)119,337USD 4,340,287RPRX holding increased by 21481USD 4,340,2870USD 21,481 USD 36.37 USD 36.19
2025-07-02 (Wednesday)119,337USD 4,318,806RPRX holding increased by 19094USD 4,318,8060USD 19,094 USD 36.19 USD 36.03
2025-06-30 (Monday)119,337USD 4,299,712RPRX holding increased by 19094USD 4,299,7120USD 19,094 USD 36.03 USD 35.87
2025-06-27 (Friday)119,337RPRX holding decreased by -1027USD 4,280,618RPRX holding increased by 35380USD 4,280,618-1,027USD 35,380 USD 35.87 USD 35.27
2025-06-26 (Thursday)120,364RPRX holding decreased by -79USD 4,245,238RPRX holding decreased by -79870USD 4,245,238-79USD -79,870 USD 35.27 USD 35.91
2025-06-25 (Wednesday)120,443USD 4,325,108RPRX holding decreased by -27702USD 4,325,1080USD -27,702 USD 35.91 USD 36.14
2025-06-24 (Tuesday)120,443RPRX holding decreased by -256USD 4,352,810RPRX holding increased by 80065USD 4,352,810-256USD 80,065 USD 36.14 USD 35.4
2025-06-23 (Monday)120,699USD 4,272,745RPRX holding increased by 65178USD 4,272,7450USD 65,178 USD 35.4 USD 34.86
2025-06-20 (Friday)120,699RPRX holding decreased by -1629USD 4,207,567RPRX holding decreased by -62903USD 4,207,567-1,629USD -62,903 USD 34.86 USD 34.91
2025-06-19 (Thursday)122,328USD 4,270,470USD 4,270,4700USD 0 USD 34.91 USD 34.91
2025-06-18 (Wednesday)122,328USD 4,270,470RPRX holding increased by 42814USD 4,270,4700USD 42,814 USD 34.91 USD 34.56
2025-06-17 (Tuesday)122,328RPRX holding decreased by -3343USD 4,227,656RPRX holding decreased by -183396USD 4,227,656-3,343USD -183,396 USD 34.56 USD 35.1
2025-06-16 (Monday)125,671USD 4,411,052RPRX holding increased by 32674USD 4,411,0520USD 32,674 USD 35.1 USD 34.84
2025-06-13 (Friday)125,671RPRX holding decreased by -395USD 4,378,378RPRX holding decreased by -67970USD 4,378,378-395USD -67,970 USD 34.84 USD 35.27
2025-06-12 (Thursday)126,066RPRX holding increased by 385USD 4,446,348RPRX holding increased by 166910USD 4,446,348385USD 166,910 USD 35.27 USD 34.05
2025-06-11 (Wednesday)125,681USD 4,279,438RPRX holding increased by 59070USD 4,279,4380USD 59,070 USD 34.05 USD 33.58
2025-06-10 (Tuesday)125,681USD 4,220,368RPRX holding increased by 23879USD 4,220,3680USD 23,879 USD 33.58 USD 33.39
2025-06-09 (Monday)125,681RPRX holding decreased by -869USD 4,196,489RPRX holding decreased by -78370USD 4,196,489-869USD -78,370 USD 33.39 USD 33.78
2025-06-06 (Friday)126,550RPRX holding decreased by -234USD 4,274,859RPRX holding decreased by -4101USD 4,274,859-234USD -4,101 USD 33.78 USD 33.75
2025-06-05 (Thursday)126,784USD 4,278,960RPRX holding increased by 39303USD 4,278,9600USD 39,303 USD 33.75 USD 33.44
2025-06-04 (Wednesday)126,784RPRX holding decreased by -1501USD 4,239,657RPRX holding decreased by -30951USD 4,239,657-1,501USD -30,951 USD 33.44 USD 33.29
2025-06-03 (Tuesday)128,285RPRX holding decreased by -395USD 4,270,608RPRX holding decreased by -9289USD 4,270,608-395USD -9,289 USD 33.29 USD 33.26
2025-06-02 (Monday)128,680USD 4,279,897RPRX holding increased by 48899USD 4,279,8970USD 48,899 USD 33.26 USD 32.88
2025-05-30 (Friday)128,680USD 4,230,998USD 4,230,998
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of RPRX by Blackrock for IE00BMWPV470

Show aggregate share trades of RPRX

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-07-10BUY474 36.120* 34.94
2025-07-09SELL-395 35.870* 34.91 Profit of 13,789 on sale
2025-07-08SELL-2,172 35.510* 34.89 Profit of 75,771 on sale
2025-06-27SELL-1,027 35.870* 34.51 Profit of 35,443 on sale
2025-06-26SELL-79 35.270* 34.47 Profit of 2,723 on sale
2025-06-24SELL-256 36.140* 34.27 Profit of 8,774 on sale
2025-06-20SELL-1,629 34.860* 34.15 Profit of 55,634 on sale
2025-06-17SELL-3,343 34.560* 33.98 Profit of 113,586 on sale
2025-06-13SELL-395 34.840* 33.76 Profit of 13,334 on sale
2025-06-12BUY385 35.270* 33.57
2025-06-09SELL-869 33.390* 33.50 Profit of 29,115 on sale
2025-06-06SELL-234 33.780* 33.44 Profit of 7,824 on sale
2025-06-04SELL-1,501 33.440* 33.28 Profit of 49,946 on sale
2025-06-03SELL-395 33.290* 33.26 Profit of 13,138 on sale
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of RPRX

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-07-30529,655432816,35164.9%
2025-07-29600,85925752,37279.9%
2025-07-28682,7281,073824,97582.8%
2025-07-25351,99350514,20168.5%
2025-07-24396,41057557,22971.1%
2025-07-23289,2172,996787,22036.7%
2025-07-22460,4210666,17169.1%
2025-07-21489,8451,682693,05470.7%
2025-07-18355,3760587,43460.5%
2025-07-17481,790152723,86866.6%
2025-07-16566,3101892,06963.5%
2025-07-15463,5241,600804,50157.6%
2025-07-14217,3080725,14730.0%
2025-07-11329,5460610,91353.9%
2025-07-10218,6450368,89759.3%
2025-07-09445,107102704,81263.2%
2025-07-081,018,06701,377,80073.9%
2025-07-07770,37501,007,56776.5%
2025-07-03241,1230377,32063.9%
2025-07-021,433,6592001,828,74978.4%
2025-07-011,066,9502711,425,25774.9%
2025-06-30762,54613,0461,489,97251.2%
2025-06-27603,202172795,37875.8%
2025-06-26561,266836948,35759.2%
2025-06-25529,803146713,37174.3%
2025-06-24715,2481,6331,233,14158.0%
2025-06-23523,97640932,42956.2%
2025-06-20405,0424,464864,54746.9%
2025-06-18495,21201,055,78546.9%
2025-06-17388,2221101,009,02538.5%
2025-06-16308,9330888,61934.8%
2025-06-13494,06815,6301,113,91044.4%
2025-06-122,522,6491014,173,23160.4%
2025-06-11606,58101,405,86043.1%
2025-06-10445,6943,5201,742,59925.6%
2025-06-09259,92947949,62227.4%
2025-06-06386,9683001,100,67135.2%
2025-06-05609,7640930,93565.5%
2025-06-04591,98830861,09468.7%
2025-06-03531,2361,144856,96762.0%
2025-06-02587,63001,310,56844.8%
2025-05-30684,55501,339,96451.1%
2025-05-29198,8343743,97426.7%
2025-05-28349,3531,038731,89747.7%
2025-05-27308,636344798,60938.6%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.